TIDMOXB
RNS Number : 0914N
Oxford Biomedica PLC
20 September 2023
Director Dealings
Oxford, UK - 20 September 2023: Oxford Biomedica plc (LSE:OXB)
("Oxford Biomedica" or "the Company"), a quality and innovation-led
cell and gene therapy CDMO, today announces the following share
purchases by certain Directors and Senior management.
Name of PDMR Number of Number of ordinary T otal number of
o rdinary shares now held ordinary shares
shares purchased held as a percentage
of the Company's
share capital
Dr. Roch Doliveux 36,130 371,805 0.385%
------------------ ------------------- ----------------------
Dr. Frank Mathias 20,000 20,000 0.020%
------------------ ------------------- ----------------------
Stuart Paynter 4,030 18,687 0.019%
------------------ ------------------- ----------------------
Leone Patterson 5,849 5,849 0.0061%
------------------ ------------------- ----------------------
Catherine Moukheibir 7,226 25,756 0.027%
------------------ ------------------- ----------------------
Stuart Henderson 1,000 10,862 0.011%
------------------ ------------------- ----------------------
Sebastien Ribault* 1,500 - -
------------------ ------------------- ----------------------
Nick Page* 11,678 - -
------------------ ------------------- ----------------------
Matthew Treagus* 3,842 - -
------------------ ------------------- ----------------------
James Miskin* 1,808 - -
------------------ ------------------- ----------------------
*Senior Management
The below notifications, made in accordance with the
requirements of the EU Market Abuse Regulation, give further
details of the number of ordinary shares purchased.
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Dr. Roch Doliveux
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Non-Executive Chairman
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7430 36,130
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 36,130
GBP99,104.59
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:27
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Dr. Frank Mathias
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Chief Executive Officer
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7498 20,000
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 20,000
GBP54,996
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:26
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Stuart Paynter
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Chief Financial Officer
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.481 4,030
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 4,030
GBP9,998.43
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 08.01
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Leone Patterson
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7445 5,849
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 5,849
GBP16,052.58
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:28
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name C atherine Moukheibir
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7430 7,226
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 7,226
GBP19,820.92
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:28
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Stuart Henderson
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Non-Executive Director
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7497 1,000
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 1,000
GBP2,749.70
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:26
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Sebastien Ribault
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Chief Commercial Officer
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.7497 1,500
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 1,500
GBP4,124.55
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:27
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Nick Page
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Chief Operations Officer
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.555 11,678
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 11,678
GBP29,837.29
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 08.08
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name Matthew Treagus
----------------------------- ------------------------------------
2. Reason for the notification
-------------------------------------------------------------------
a) Position/status Chief Information Officer and Chief
of Staff
----------------------------- ------------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- ------------------------------------
3. Details of the Issuer
-------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- ------------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- ------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
-------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- ------------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- ------------------------------------
c) Currency GBP - British pound
----------------------------- ------------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.587949 3,842
----------
----------------------------- ------------------------------------
e) Aggregated information
* Aggregate volume 3,842
GBP9,942.90
* Aggregated total
----------------------------- ------------------------------------
f) Date of the transaction 2023-09-20; 08.05
----------------------------- ------------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- ------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")
a) Name James Miskin
----------------------------- -----------------------------------
2. Reason for the notification
------------------------------------------------------------------
a) Position/status Chief Technical Officer
----------------------------- -----------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------- -----------------------------------
3. Details of the Issuer
------------------------------------------------------------------
a) Name Oxford Biomedica plc
----------------------------- -----------------------------------
b) LEI code 213800S1GVQNXQ15K851
----------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
------------------------------------------------------------------
a) Description of Ordinary Shares of 50 pence each
the financial
instrument
ISIN: GB00BDFBVT43
Identification
code
----------------------------- -----------------------------------
b) Nature of the P urchase of shares
transaction
----------------------------- -----------------------------------
c) Currency GBP - British pound
----------------------------- -----------------------------------
d) Price(s) and volumes(s) Price(s) Volume(s)
GBP2.74 1,808
----------
----------------------------- -----------------------------------
e) Aggregated information
* Aggregate volume 1,808
GBP4,953.92
* Aggregated total
----------------------------- -----------------------------------
f) Date of the transaction 2023-09-20; 10:55
----------------------------- -----------------------------------
g) Place of the transaction London Stock Exchange, Main Market
(XLON)
----------------------------- -----------------------------------
-Ends-
For further information, please
contact:
Oxford Biomedica plc: Tel: +44 (0)1865 783 000
Natalie Walter, Company Secretary
About Oxford Biomedica
Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell
and gene therapy CDMO with a mission to enable its clients to
deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, the
Company has more than 25 years of experience in viral vectors; the
driving force behind the majority of gene therapies. The Company
collaborates with some of the world's most innovative
pharmaceutical and biotechnology companies, providing viral vector
development and manufacturing expertise in lentivirus,
adeno-associated virus (AAV) and adenoviral vectors. Oxford
Biomedica's world-class capabilities span from early-stage
development to commercialisation. These capabilities are supported
by robust quality-assurance systems, analytical methods and depth
of regulatory expertise.
Oxford Biomedica, a FTSE4Good constituent, is headquartered in
Oxford, UK. It has locations across Oxfordshire, UK and near
Boston, MA, US. Learn more at www.oxb.com , www.oxbsolutions.com ,
and follow us on LinkedIn and YouTube .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDZGZLGGGGFZM
(END) Dow Jones Newswires
September 20, 2023 06:42 ET (10:42 GMT)
Oxford Biomedica (AQSE:OXB.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Oxford Biomedica (AQSE:OXB.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
